Home » Topics » Disease categories and therapies » Hematologic

Hematologic
RSS

First Rx for HIT type II approved in U.S.

March 10, 1998

U.S. patent covers use of MH-1 to deliver thrombolytics

March 5, 1998

3-D reveals new trypsin-like serine protease inhibitors

March 4, 1998

Acetaminophen increases risk of hemorrhage in combination with warfarin

March 4, 1998

Anticoagulants under development at Astra

March 3, 1998

Saruplase found equivalent to streptokinase in COMPASS trial

March 3, 1998

Corvas prepares new orally active antithrombotic agents

March 2, 1998

Orally active thrombin inhibitors prepared at C&C

Feb. 27, 1998

Cor Therapeutics receives milestone for Integrilin MAA review

Feb. 23, 1998

FDA accepts The Medicines Company's NDA for Hirulog

Feb. 20, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...